First Time Loading...

Indoco Remedies Ltd
NSE:INDOCO

Watchlist Manager
Indoco Remedies Ltd Logo
Indoco Remedies Ltd
NSE:INDOCO
Watchlist
Price: 305.2 INR 1.58% Market Closed
Updated: Jun 3, 2024
Section:
 

Relative Value

The Relative Value of one INDOCO stock under the Base Case scenario is 544.19 INR. Compared to the current market price of 305.2 INR, Indoco Remedies Ltd is Undervalued by 44%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

INDOCO Relative Value
Base Case
544.19 INR
Undervaluation 44%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.1
P/S
P/S
Price to Sales
2.1
vs History
57
vs Industry
52
Median 3Y
2.3
Median 5Y
2.1
Industry
2.4
Forward
1.5
More Details
37.1
P/E
P/E
Price to Earnings
37.1
vs History
42
vs Industry
13
Median 3Y
28.3
Median 5Y
35.6
Industry
22.4
Forward
26.8
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
22
Median 3Y
19
Median 5Y
-84.4
Industry
16.9
More Details
55.2
P/FCFE
P/FCFE
Price to FCFE
55.2
vs History
41
vs Industry
11
Median 3Y
67.1
Median 5Y
-286.5
Industry
22.6
More Details
2.6
P/B
P/B
Price to Book Value
2.6
vs History
90
vs Industry
31
Median 3Y
3.4
Median 5Y
3.4
Industry
2
More Details
2.2
EV/S
EV/S
Enterprise Value to Sales
2.2
vs History
52
vs Industry
49
Median 3Y
2.4
Median 5Y
2.3
Industry
2.5
Forward
1.7
More Details
3.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.2
vs History
50
vs Industry
59
Median 3Y
3.5
Median 5Y
3.3
Industry
5.1
More Details
22.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
22.5
vs History
46
vs Industry
17
Median 3Y
12.6
Median 5Y
22.3
Industry
13.3
Forward
11.6
More Details
23.5
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
23.5
vs History
46
vs Industry
19
Median 3Y
18.5
Median 5Y
23.2
Industry
16.6
Forward
17.4
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
23
Median 3Y
19.1
Median 5Y
-91.1
Industry
15.7
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
2
Median 3Y
151.2
Median 5Y
-50.3
Industry
17.7
More Details
1.7
EV/IC
EV/IC
Enterprise Value to IC
1.7
vs History
90
vs Industry
42
Median 3Y
2.4
Median 5Y
2.3
Industry
1.9
More Details

Multiples Across Competitors

INDOCO Competitors Multiples
Indoco Remedies Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Indoco Remedies Ltd
NSE:INDOCO
28.1B INR 2.1 37.1 22.5 23.5
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
789.2B USD 22 128.7 62.8 71.5
DK
Novo Nordisk A/S
CSE:NOVO B
4.1T DKK 16.9 46.2 34.4 37.7
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
356.5B USD 4.2 9.3 11.4 14.9
US
Merck & Co Inc
NYSE:MRK
324.3B USD 5.3 140.3 35.1 57.2
UK
AstraZeneca PLC
LSE:AZN
191.4B GBP 5.1 38.5 174.9 279
CH
Roche Holding AG
SIX:ROG
184.3B CHF 3.1 16 9.1 10.8
CH
Novartis AG
SIX:NOVN
181.3B CHF 3.4 11.5 8.7 12.8
US
Pfizer Inc
NYSE:PFE
165.6B USD 3 -535.8 12.9 20.9
P/E Multiple
Earnings Growth
IN
Indoco Remedies Ltd
NSE:INDOCO
Average P/E: 53.5
37.1
13%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
128.7
364%
DK
Novo Nordisk A/S
CSE:NOVO B
46.2
83%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
US
Johnson & Johnson
NYSE:JNJ
9.3
-21%
US
Merck & Co Inc
NYSE:MRK
140.3
7 598%
UK
AstraZeneca PLC
LSE:AZN
38.5
175%
CH
Roche Holding AG
SIX:ROG
16
28%
CH
Novartis AG
SIX:NOVN
11.5
17%
US
Pfizer Inc
NYSE:PFE
Negative Multiple: -535.8
683%

See Also

Summary
INDOCO intrinsic value, competitors valuation, and company profile.
DCF Valuation
INDOCO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
INDOCO stock valuation using valuation multiples.
Wall Street Estimates
INDOCO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
INDOCO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 143,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.